XML 62 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of changes in share capital

    

Premiums 

Share 

related to 

Number of 

Nominal 

Date

    

Nature of the transactions

    

capital

    

share capital

    

shares

    

value

Balance as of January 1st, 2020

 

268,461

 

86,011,893

 

26,846,112

 

0.01

01/26/2020

Capital increase by issuance of ordinary shares – Vesting of AGAs by Company employees (AGA 2018-2)

 

633

 

 

63,300

 

0.01

02/07/2020

Capital increase by issuance of ordinary shares – Company’s private placement

 

37,783

 

14,962,218

 

3,778,338

 

0.01

02/07/2020

Transaction costs related to the Company’s private placement

 

 

(319,564)

 

 

04/17/2020

Appropriation of the issue premium

 

 

(48,000,000)

 

 

06/28/2020

Capital increase by issuance of ordinary shares – Vesting of AGAs by Company employees (AGA 2019-2)

2,270

227,000

0.01

07/15/2020

Capital increase by issuance of ordinary shares – Company’s initial public offering

74,783

94,024,272

7,478,261

0.01

07/15/2020

Transaction costs related to the Company’s initial public offering

 

 

(7,077,866)

 

 

11/30/2020

Capital increase by emission of ordinary shares – Emission of 10,000 BSA

 

100

 

66,650

 

10,000

 

0.01

12/14/2020

Capital increase by issuance of ordinary shares – Vesting of AGAs by Company employees (AGA 2018-3)

 

2,273

 

 

227,250

 

0.01

Balance as of December 31, 2020

386,302

139,667,603

38,630,261

0.01

06/28/2021

Capital increase by issuance of ordinary shares – Vesting of AGAs by Company employees (AGA 2019-1)

291

29,100

0.01

09/27/2021

Capital increase by issuance of ordinary shares – (ATM)

20,833

25,556,803

2,083,334

0.01

10/01/2021

Capital increase by issuance of ordinary shares – (ATM)

1,309

1,615,584

130,856

0.01

10/01/2021

Transaction costs related to ATM

(1,768,424)

Balance as of December 31, 2021

408,735

165,071,566

40,873,551

0.01

15/06/2022

Capital increase by issue of ordinary shares - (ATM3)

12,606

9,353,504

1,260,618

0.01

15/06/2022

Transaction costs related to ATM

(539,404)

Balance as of December 31, 2022

421,341

173,885,665

42,134,169

0.01

BSPCE and BSA share warrants  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

    

    

Exercise

    

Outstanding

    

    

    

    

Outstanding

    

Number of

price

at January 1,

at December 31,

shares

Type

    

Grant date

    

(in euros)

    

2022

    

Issued

    

Exercised

    

Forfeited

    

2022

    

exercisable

BSPCE — 2013 plan

 

Dec. 13, 2013

 

0.59

 

8,800

 

 

 

 

8,800

 

8,800

BSPCE Plan 2021

April 16, 2021

11.74

600,000

(120,000)

480,000

Total BSPCE

 

  

 

  

 

608,800

 

 

 

(120,000)

 

488,800

 

8,800

BSA — 2017 plan

 

May 29, 2017

 

6.67

 

130,000

 

 

 

 

130,000

 

130,000

BSA — 2018 plan

 

Dec. 14, 2018

 

6.07

 

116,000

 

 

 

 

116,000

 

116,000

BSA — 2019 plan

 

June 28, 2019

 

2.20

 

10,000

 

 

 

 

10,000

 

10,000

BSA 2019 Bis

March 9, 2020

3.68

10,000

10,000

10,000

BSA 2019 Ter

March 9, 2020

3.68

36,000

36,000

24,000

BSA - Plan 2021-1

April 16, 2021

11.74

20,000

(4,000)

16,000

Total BSA

 

  

 

  

 

322,000

 

 

 

(4,000)

 

318,000

 

290,000

Total

 

930,800

 

 

 

(124,000)

 

806,800

 

298,800

    

    

Exercise

    

Outstanding

    

    

    

    

Outstanding

    

Number of

price

at January 1,

at December 31,

shares

Type

Grant date

    

(in euros)

    

2021

    

Issued

    

Exercised

    

Forfeited

    

2021

    

exercisable

BSPCE — 2013 plan

Dec. 13, 2013

 

0.59

 

8,800

 

 

 

 

8,800

 

8,800

BSPCE Plan 2021

April 16, 2021

 

11.74

 

 

600,000

 

 

 

600,000

 

Total BSPCE

  

 

  

 

8,800

 

600,000

 

 

 

608,800

 

8,800

BSA — 2017 plan

May 29, 2017

 

6.67

 

130,000

 

 

 

 

130,000

 

130,000

BSA — 2018 plan

Dec. 14, 2018

 

6.07

 

116,000

 

 

 

 

116,000

 

116,000

BSA — 2019 plan

June 28, 2019

2.20

10,000

10,000

10,000

BSA 2019 Bis

March 9, 2020

3.68

10,000

10,000

10,000

BSA 2019 Ter

March 9, 2020

 

3.68

 

36,000

 

 

 

 

36,000

 

12,000

BSA - Plan 2021-1

April 16, 2021

 

11.74

 

 

50,000

 

 

(30,000)

 

20,000

 

Total BSA

  

302,000

50,000

(30,000)

322,000

278,000

Total

310,800

650,000

(30,000)

930,800

286,800

    

    

Exercise

    

Outstanding

    

    

    

    

Outstanding

    

Number of

price

at January 1,

at December 31,

shares

Type

    

Grant date

    

(in euros)

    

2020

    

Issued

    

Exercised

    

Forfeited

    

2020

    

exercisable

BSPCE — 2013 plan

 

Dec. 13, 2013

 

0.59

 

8,800

 

 

 

 

8,800

 

8,800

Total BSPCE

 

 

 

8,800

 

 

 

 

8,800

 

8,800

BSA — 2017 plan

 

May 29, 2017

 

6.67

 

140,000

 

 

(10,000)

 

 

130,000

 

130,000

BSA — 2018 plan

 

Dec. 14, 2018

 

6.07

 

116,000

 

 

 

 

116,000

 

77,334

BSA — 2019 plan

 

June 28, 2019

 

2.20

 

10,000

 

 

 

 

10,000

 

10,000

BSA 2019 Bis

March 9, 2020

3.68

10,000

10,000

BSA 2019 Ter

 

March 9, 2020

 

3.68

 

 

36,000

 

 

 

36,000

 

Total BSA

 

266,000

 

46,000

 

(10,000)

 

 

302,000

 

217,334

Total

274,800

46,000

(10,000)

310,800

226,134

BSPCE Share Warrants [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

    

BSPCE 2013-1

    

BSPCE 2021

 

Decision of issuance by the Board of Directors

 

13/12/2013

04/16/2021

Grant date

 

13/12/2013

04/16/2021

Beneficiary

 

3 employees

Executive Directors (Frederic Cren and Pierre Broqua)

Number of BSPCE granted

 

9 027

600,000

Expiration date

 

25/01/2024

03/31/2034

Number of shares per BSPCE

 

100

1

Subscription price (€)

58.50

0

Exercise price (€)

0.585

11.74

Performance condition

No

Partially (1)

Valuation method used

Black and Scholes

Monte Carlo

Fair value at grant date (€)

19

[5.4 – 5.7] (1)

Expected volatility

35

%

64

%

Average life (years)

5

5

Risk-free rate

1.13

%

0.60

%

Expected dividends

 

(1)The fair value at grant date is different depending on whether the BSPCEs are subject to market performance conditions.
BSA Share warrant [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

    

    

BSA

BSA

 

    

BSA 2017

    

2018-1

    

BSA 2019

    

2019 bis

    

BSA 2019 ter

    

BSA 2021

 

Decision of issuance by the Board of Directors

05/29/2017

12/14/2018

 

06/28/2019

 

03/09/2020

 

03/09/2020

04/16/2021

Grant date

05/29/2017

12/14/2018

 

06/28/2019

 

03/09/2020

 

03/09/2020

04/16/2021

Beneficiary

Directors

Service providers

 

Service providers

 

Service providers

 

Service providers

Service providers

Vesting period (year)

3 tranches: 1 year, 2 years and 3 years

between 1 and 3 years

 

1

 

1

 

between 1 and 3 years

3

Expiration date

05/29/2027

12/14/2028

 

06/28/2029

 

03/09/2030

 

03/09/2030

03/31/2034

Number of BSA granted

195,000

126,000

 

10,000

 

10,000

 

36,000

50,000

Number of shares per BSA

1

1

 

1

 

1

 

1

1

Subscription premium price per share (€)

0.534

0.48

 

0.18

 

0.29

 

0.29

2.45

Exercise price per share (€)

6.675

6.067

 

2.20

 

3.68

 

3.68

11.74

Performance condition

No

No

 

No

 

No

 

No

Yes

Valuation method

Black and Scholes

Monte Carlo

Fair value per BSA at grant date (€)

2.47

1.98

0.48

0.90

0.90

[3.0 – 3.2] (1)

Expected volatility

40

%

40

%

40

%

40

%

40

%

64

%

Average life (years)

6

6

5.5

6

6

5

Risk free rate

0.22

%

0.30

%

0.33

%

0.0

%

0.0

%

0.60

%

Expected dividends

 

 

 

(1)

The fair value at grant date is different depending on whether the BSPCEs are subject to market performance conditions.

AGA Bonus Share Award Plans Member  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

    

AGA 2021

    

AGA 2021-bis

    

AGA 2022

Decision of issuance by the Board of Directors

 

04/16/2021

 

12/08/2021

12/08/2022

Grant date

 

04/16/2021

 

12/08/2021

12/08/2022

Beneficiary

 

Employees

 

Employees

Employees

Vesting period (year)

 

3

 

3

1

Holding period (year)

 

 

1

Service condition

 

Yes

 

Yes

Yes

Performance condition

 

Partially (1)

 

Partially (1)

No

Number of AGA granted

 

466,000

 

123,000

373,000

Number of shares per AGA

 

1

 

1

1

Valuation method used

Dual (1)

Dual (1)

Dual(1)

Fair value per AGA at grant date

[9.8 – 11.3] (1)

[11.4 – 12.2] (1)

4.18

Expected volatility

64

%

64

%

N/A

Average life (years)

3

2.3

N/A

Risk-free rate

0.60

%

0.60

%

N/A

Expected dividends

Stock price reference

N/A

N/A

N/A

Non-transferable discount

 

N/A

 

N/A

N/A

(1)AGA 2021-1 and AGA 2021-bis plans are partially composed of AGAs subject to a market performance condition. AGAs 2022 aren’t subject to a market performance condition. Accordingly, AGAs not subject to performance conditions are valued on the basis of the share price less future dividends, discounted at the risk-free rate. AGAs subject to performance conditions are valued using the same method, adjusted by a discount applied to reflect the performance condition. This discount is determined using the “Monte Carlo” analysis. The fair value at the grant date is different depending on whether the AGAs are subject to market performance conditions.
Bonus Share Award Plans [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

Stock price

Outstanding

Outstanding

Number of

at grant date

at January 1,

at December 31,

shares

Type

    

Grant date

    

(in euros)

    

2022

    

Issued

    

vesting

    

Forfeited

    

2022

    

exercisable

AGA — 2021‑1 plan

 

04/16/21

 

11.30

 

448,000

 

 

 

(107,200)

 

340,800

 

AGA — 2021‑bis plan

 

12/08/21

 

12.20

 

123,000

 

 

 

(46,200)

 

76,800

 

AGA —2022 plan

12/08/22

4.18

373,000

373,000

Total AGA

 

571,000

 

373,000

 

 

(153,400)

 

790,600

 

Stock price

Outstanding

at grant

Outstanding

at

Number of

date

at January 1,

December 31,

shares

Type

    

Grant date

    

(in euros)

    

2021

    

Issued

    

vesting

    

Forfeited

    

2021

    

exercisable

AGA — 2019‑1 plan

 

08/28/19

 

2.00

 

29,100

 

 

(29,100)

 

 

 

AGA — 2021‑1 plan

 

04/16/21

 

11.30

 

 

466,000

 

 

(18,000)

 

448,000

 

AGA —2021‑bis plan

 

08/12/21

 

12.20

 

 

123,000

 

 

 

123,000

 

Total AGA

 

  

 

  

 

29,100

 

589,000

 

(29,100)

 

(18,000)

 

571,000

 

Stock

price

at grant

Outstanding

Outstanding

Number of

date

at January 1,

at December 31,

shares

Type

    

Grant date

    

(in euros)

    

2020

    

Issued

    

vesting

    

Forfeited

    

2020

    

exercisable

AGA — 2018-2 plan

January 26, 2018

 

5.76

 

63,300

 

 

(63,300)

 

 

 

AGA — 2018-3 plan

December 14, 2018

 

6.28

 

227,250

 

 

(227,250)

 

 

 

AGA — 2019-1 plan

June 28, 2019

 

2.00

 

37,500

 

 

 

(8,400)

 

29,100

 

AGA — 2019-2 plan

June 28, 2019

 

2.00

 

228,000

 

 

(227,000)

 

(1,000)

 

 

Total AGA

 

556,050

 

 

(517,550)

 

(9,400)

 

29,100